Apidra and Jakafi

• Generic Name: insulin glulisine
• Dosage Forms: injection, solution
• Other Brand Names: Apidra, Apidra OptiClik Cartridge, Apidra SoloStar Pen

Apidra is an injection that contains insulin glulisine. Insulin is a hormone that works by lowering levels of glucose (sugar) in the blood. Insulin glulisine is a fast-acting insulin that starts to work about 15 minutes after injection, peaks in about 1 hour, and keeps working for 2 to 4 hours.

Apidra is used to improve blood sugar control in adults and children with diabetes mellitus.

Apidra is used to treat type 1 or type 2 diabetes in adults, and type 1 diabetes children who are at least 4 years old.

• Generic Name: ruxolitinib
• Dosage Forms: tablet
• Other Brand Names: Jakafi

Jakafi (ruxolitinib) works by blocking certain enzymes in the body that affect blood cell production.

Jakafi is used to treat myelofibrosis or polycythemia vera, which are bone marrow disorders that that affect your body's ability to produce blood cells.

Jakafi is also used to treat acute graft versus host disease (GVHD) in adults and children 12 years of age and older who have taken corticosteroids and they did not work well enough.

Jakafi may also be used for purposes not listed in this medication guide.